Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
My order arrived within about 2 days after I spoke with the doctor
What the Research Actually Shows Published research on AOD-9604 describes: Modest body fat reduction in preclinical and early clinical settings Reduced triglycerides in some studies Minimal effect on IGF-1 confirmed across the clinical dataset Good tolerability adverse event rates in the phase 2 obesity trials were comparable to placebo Variable weight loss some patients respond better than others, consistent with many metabolic interventions The effect size in phase 2 obesity trials was modest typically in the range of a few pounds over the study period
Beretta, G
(2022) Lee and Burgess (2025) Mayfield et al
US$ 23.60
US$ 23.39
US$ 28.19
US$ 29.34
US$ 22.67
US$ 26.00
